Content area
Full text
[Image omitted] - (http://www.fiercepharma.com/story/mercks-frazier-joins-top-paid-pharma-ceos-25m-package/2015-04-14)
Merck CEO Kenneth Frazier
Thanks to a big stock grant, Merck & Co.'s ($MRK) Kenneth Frazier vaulted to the highest echelons of pharma CEO pay last year. With a pay package valued at more than $25 million, Frazier beat out Pfizer's ($PFE) Ian Read and Johnson & Johnson's ($JNJ) Alex Gorsky --even if he fell far short of Regeneron ($REGN) chief Len Schleifer .
Frazier's executive team all saw their compensation packages grow in 2014, too, partly because of a new method for valuing long-term stock grants. But the entire group's cash incentive pay also jumped significantly. And for the second year in a row, R&D chief Roger Perlmutter got a cash bonus of $500,000, while brand-new CFO Robert Davis took down a $2.5 million signing bonus.
At $1.5 million, Frazier's base salary has remained steady for several years running. But his cash incentive pay more than doubled year-over-year, to $3.34 million....